Back
Cartesian Therapeutics, Inc. Stock Price Chart
Valuation Up 5,000%. Shares Now $0.85 - Still Early?
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
23
RNAC
Cartesian Therapeutics, Inc.
Last Price:
$7.22
Seasonality Move:
0.08%
7 Day Trial
ALL ACCESS PASS
$
7
Share Price Moved. Momentum Hasn't Slowed.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RNAC is experiencing slight selling pressure.
Cartesian Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.1 | Sell |
| 20-day SMA: | 7.51 | Sell |
| 50-day SMA: | 8.05 | Sell |
| 200-day SMA: | 10.65 | Sell |
| 8-day EMA: | 2.92 | Buy |
| 20-day EMA: | 1.34 | Buy |
| 50-day EMA: | 0.57 | Buy |
| 200-day EMA: | 0.15 | Buy |
Cartesian Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.04 | Buy |
| Relative Strength Index (14 RSI): | 45.43 | Sell |
| Chaikin Money Flow: | -84704 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.91 - 8.05) | Sell |
| Bollinger Bands (100): | (7.75 - 10.85) | Sell |
Cartesian Therapeutics, Inc. Technical Analysis
| Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Cartesian Therapeutics, Inc. Stock
Is Cartesian Therapeutics, Inc. Stock a Buy?
-
Cartesian Therapeutics, Inc. share price is 7.36 while RNAC 8-day simple moving average is 8.10, which is a Sell signal.
-
The stock price of RNAC is 7.36 while Cartesian Therapeutics, Inc. 20-day SMA is 7.51, which makes it a Sell.
-
Cartesian Therapeutics, Inc. 50-day simple moving average is 8.05 while RNAC share price is 7.36, making it a Sell technically.
-
RNAC stock price is 7.36 and Cartesian Therapeutics, Inc. 200-day simple moving average is 10.65, creating a Sell signal.
RNAC Technical Analysis vs Fundamental Analysis
Sell
23
Cartesian Therapeutics, Inc. (RNAC)
is a Sell
Is Cartesian Therapeutics, Inc. a Buy or a Sell?
-
Cartesian Therapeutics, Inc. stock is rated a SellThe current Cartesian Therapeutics, Inc. [RNAC] share price is $7.36. The Score for RNAC is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
Cartesian Therapeutics, Inc. Stock Info
Market Cap:
191.4M
Price in USD:
7.36
Share Volume:
190.6K
Cartesian Therapeutics, Inc. 52-Week Range
52-Week High:
20.30
52-Week Low:
5.98
Sell
23
Cartesian Therapeutics, Inc. (RNAC)
is a Sell
Cartesian Therapeutics, Inc. Share Price Forecast
-
What is the Cartesian Therapeutics, Inc. stock price today?The Cartesian Therapeutics, Inc. stock price is 7.36 USD today.
-
Will RNAC stock go up or go down?Cartesian Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Cartesian Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cartesian Therapeutics, Inc. is overvalued.
Is Cartesian Therapeutics, Inc. Stock a Buy?
-
Cartesian Therapeutics, Inc. share price is 7.36 while RNAC 8-day exponential moving average is 2.92, which is a Buy signal.
-
The stock price of RNAC is 7.36 while Cartesian Therapeutics, Inc. 20-day EMA is 1.34, which makes it a Buy.
-
Cartesian Therapeutics, Inc. 50-day exponential moving average is 0.57 while RNAC share price is 7.36, making it a Buy technically.
-
RNAC stock price is 7.36 and Cartesian Therapeutics, Inc. 200-day simple moving average is 0.15, creating a Buy signal.
Fundamental Analysis of Cartesian Therapeutics, Inc.
Is Cartesian Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.19 per share, and a decrease next year of $0.65 per share.
Technical Analysis of Cartesian Therapeutics, Inc.
Should I short Cartesian Therapeutics, Inc. stock?
-
RNAC Moving Average Covergence Divergence (MACD) indicator is 1.04, suggesting Cartesian Therapeutics, Inc. is a Buy
-
Cartesian Therapeutics, Inc. Relative Strength Index (RSI) is 45.43, which suggest Cartesian Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Cartesian Therapeutics, Inc. is (6.91 - 8.05), which suggest Cartesian Therapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for Cartesian Therapeutics, Inc. is (7.75 - 10.85), which suggest Cartesian Therapeutics, Inc. is a Sell
* Cartesian Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.